Comparison of Intralesional Tranexamic Acid and Platelets Rich Plasma in the Treatment of Melasma

PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 1, 2022

Primary Completion Date

April 30, 2023

Study Completion Date

April 30, 2023

Conditions
Melasma
Interventions
DRUG

Tranexamic acid

Group A 30 patients treated with Intradermal Tranexamic acid injection (4mg/ml) for preparation an insulin syringe was used with a volume of 1ml containing 0.04 ml of TXA and the reminder being normal saline to ensure 4mg preparation in each insulin syringe

DRUG

Platelets rich plasma

Group B 30 patients prescribed with PRP (1ml) intra-dermally PRP was obtained manually by a two-step procedure using a centrifuge machine. First spin was performed at 1500 RPM for 10 minutes. Second spin was performed at 4000 RPM for 10 minutes. Thus, obtaining a two-part plasma. Upper two third was platelet poor plasma and was discarded. Lower one third was platelets rich plasma. Before injection applying 0.1 ml calcium chloride was added for each 1 ml of PRP to activate the platelets. PRP was injected 1 ml by using 30 G needle (insulin syringe) in each cm2 of melasma.

Trial Locations (3)

22010

Dr sana aslam, Abbottabad

Sana aslam, Abbottabad

Sana aslam, Abbottābād

All Listed Sponsors
lead

Combined Military Hospital Abbottabad

OTHER